Pyxis Oncology Inc. (PYXS)
NASDAQ: PYXS
· Real-Time Price · USD
1.21
0.08 (7.08%)
At close: Aug 15, 2025, 3:59 PM
1.21
0.00%
After-hours: Aug 15, 2025, 07:37 PM EDT
Pyxis Oncology Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -21.16M | -35.57M | -21.2M | -17.3M | -3.26M | -15.6M | -23.05M | -15.9M | -19.24M | -36.1M | -27.67M | -25.56M | -31.38M | -16.83M | -14.18M | -8.15M | -36.83M |
Depreciation & Amortization | 552K | 550K | 731K | 585K | 1.12M | 763K | 523K | 524K | 190K | 192K | 200K | 159K | 158K | 158K | 159K | 217K | 113K |
Stock-Based Compensation | 3.63M | 2.77M | 2.98M | 2.87M | 4.32M | 3.21M | 5.18M | 3.67M | 4.88M | 3.9M | 4.45M | 4.01M | 3.4M | 3.11M | 307K | 572K | 2.45M |
Other Working Capital | n/a | -6.65M | 10M | 1.13M | -12.4M | -2.66M | 2.63M | 3.32M | 753K | 6.96M | 4.47M | -8.4M | 9.8M | -3.21M | 2.73M | 7.85M | -5.34M |
Other Non-Cash Items | n/a | 19.62M | -6.58M | -1.47M | -1.12M | 3.06M | 154K | 175K | -463K | 9.55M | 307K | 316K | 232K | 156K | 153K | 78K | 20.22M |
Deferred Income Tax | n/a | -2.16M | n/a | n/a | n/a | -4.39M | -1.48M | -1.26M | n/a | n/a | n/a | n/a | n/a | 410K | 2.56M | 2.21M | 1.1M |
Change in Working Capital | n/a | -6.66M | 9.4M | 12.3M | -21.77M | -2.31M | 1.09M | 1.76M | -12.21M | 5.07M | 2.16M | -2.64M | -93K | 824K | 3.71M | 7.93M | -5.79M |
Operating Cash Flow | -22.54M | -19.29M | -14.66M | -3.01M | -20.71M | -15.25M | -17.58M | -11.03M | -26.84M | -17.39M | -20.56M | -23.71M | -27.68M | -12.17M | -7.29M | 2.86M | -18.73M |
Capital Expenditures | n/a | n/a | n/a | n/a | -237K | n/a | -61K | -2.26M | -4.41M | -1.86M | -4.27M | -129K | -146K | -401K | n/a | -371K | -169K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | 1K | 6.66M | -15.19M | n/a | n/a | n/a | n/a | n/a | 50K | n/a | n/a | -50K |
Purchase of Investments | -51.35M | -4.37M | -23.64M | -39.31M | -92.79M | -10.23M | -56.43M | -35.19M | -94.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | 31.03M | -113.85M | 39.32M | 74.53M | 20.45M | 56.4M | 15.19M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 67.17M | n/a | 137.48M | n/a | -18.26M | 10.23K | -27 | 15.19M | -94.99K | n/a | n/a | n/a | n/a | -100K | n/a | n/a | -50K |
Investing Cash Flow | 15.82M | 26.66M | -8K | 4K | -18.5M | 10.23M | 6.57M | -22.25M | -99.39M | -1.86M | -4.27M | -129K | -146K | -451K | n/a | -371K | -219K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | 239K | -43K | -196K | -52 | -393 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 129K | 71K | 110K | 49K | -25K | -171K | 3K | n/a | -6K | 6K | 1K | 176K | 2.6M | -1.71M | -682K | -47K |
Financial Cash Flow | n/a | 129K | 1.66M | 110K | 57.51M | -25K | -171K | 6.13M | n/a | 177K | 6K | 1K | 176K | 154.9M | -1.71M | -682K | 151.53M |
Net Cash Flow | -6.71M | 7.42M | -13.02M | -2.89M | 18.3M | -5.05M | -11.18M | -27.16M | -126.23M | -19.25M | -24.82M | -23.84M | -27.65M | 142.73M | -8.99M | 1.81M | 132.58M |
Free Cash Flow | -22.54M | -19.29M | -14.66M | -2.94M | -20.95M | -15.25M | -17.64M | -13.29M | -31.25M | -19.25M | -24.82M | -23.84M | -27.82M | -12.57M | -7.29M | 2.49M | -18.9M |